Olema Pharmaceuticals, Inc. OLMA Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s total equity?
- Olema Pharmaceuticals, Inc. (OLMA) reported total equity of $480.48M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s total equity changed year-over-year?
- Olema Pharmaceuticals, Inc.'s total equity increased by 25.3% year-over-year, from $383.45M to $480.48M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s total equity?
- Over 5 years (2020 to 2025), Olema Pharmaceuticals, Inc.'s total equity has grown at a 7.2% compound annual growth rate (CAGR), from $338.14M to $478.56M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.